{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:02:42Z","timestamp":1781164962776,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.nbd.2008.09.018","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T05:32:13Z","timestamp":1222925533000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol"],"prefix":"10.1016","volume":"33","author":[{"given":"Jennifer M.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey J.","family":"Bergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Rowbotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nbd.2008.09.018_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00442800","article-title":"SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?","volume":"99","author":"Acquas","year":"1989","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.nbd.2008.09.018_bib3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(25)10296-6","article-title":"Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats","volume":"264","author":"Bals-Kubik","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/0735-7044.119.1.213","article-title":"Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism","volume":"119","author":"Bechtholt","year":"2005","journal-title":"Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.nbd.2008.09.018_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0447.1992.tb03316.x","article-title":"Controlled trials of antabuse in alcoholism\u2014importance of supervision and adequate dosage","volume":"69","author":"Brewer","year":"1992","journal-title":"Acta Psychiatrica Scandanavica"},{"issue":"6","key":"10.1016\/j.nbd.2008.09.018_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"10.1016\/j.nbd.2008.09.018_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1524-4733.2003.65269.x","article-title":"Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes","volume":"6","author":"Cramer","year":"2003","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1530-0277.1996.tb01669.x","article-title":"Effects of naloxone on limited-access ethanol drinking in rats","volume":"20","author":"Davidson","year":"1996","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.nbd.2008.09.018_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1530-0277.1999.tb04099.x","article-title":"Effects of naltrexone on alcohol self-administration in heavy drinkers","volume":"23","author":"Davidson","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3565(25)12080-6","article-title":"Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats","volume":"275","author":"de Waele","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.npp.1300101","article-title":"A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene","volume":"28","author":"Drobes","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.nbd.2008.09.018_bib15","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/hmg\/ddn068","article-title":"A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence","volume":"17","author":"Edenberg","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.nbd.2008.09.018_bib16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1530-0277.2002.tb02682.x","article-title":"A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial","volume":"26","author":"Guardia","year":"2002","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.biopsych.2006.09.038","article-title":"New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials","volume":"61","author":"Gueorguieva","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial","volume":"21","author":"Heinala","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.nbd.2008.09.018_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3565(25)22236-4","article-title":"Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.","volume":"250","author":"Heishman","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.nbd.2008.09.018_bib20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1530-0277.1999.tb04669.x","article-title":"Central administration of an opiate antagonist decreases oral ethanol self-administration in rats","volume":"23","author":"Heyser","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1530-0277.2001.tb02123.x","article-title":"Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats","volume":"25","author":"Hyyti\u00e4","year":"2001","journal-title":"Alcohol Clin Exp Res."},{"issue":"8","key":"10.1016\/j.nbd.2008.09.018_bib22","first-page":"1455","article-title":"Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL\/6 and DBA\/2 mice","volume":"21","author":"Jamensky","year":"1997","journal-title":"Alcohol Clin Exp Res."},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.ALC.0000122764.60626.AF","article-title":"Alcohol-related olfactory cues activate the nucleus accumbens and ventral tegmental area in high-risk drinkers: preliminary findings","volume":"28","author":"Kareken","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.nbd.2008.09.018_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(02)00308-3","article-title":"The Kreek\u2013McHugh\u2013Schluger\u2013Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications","volume":"69","author":"Kellogg","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib26","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.ALC.0000145688.30448.2C","article-title":"Effectiveness of naltrexone in a community treatment program","volume":"28","author":"Killeen","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(90)90894-H","article-title":"Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes","volume":"516","author":"Kim","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2008.09.018_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu. Rev. Psychol."},{"issue":"2\u20133","key":"10.1016\/j.nbd.2008.09.018_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0149-7634(89)80022-3","article-title":"Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence","volume":"13","author":"Koob","year":"1989","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.nbd.2008.09.018_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0893-133X(99)00135-9","article-title":"Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial","volume":"22","author":"Kranzler","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(24)37950-9","article-title":"Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions","volume":"288","author":"Kreek","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.nbd.2008.09.018_bib32","first-page":"775","article-title":"How to get the best out of antabuse","volume":"30","author":"Kristenson","year":"1995","journal-title":"Alcohol Alcohol"},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/j.1326-5377.2002.tb04550.x","article-title":"Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting","volume":"176","author":"Latt","year":"2002","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/alcalc\/agh163","article-title":"Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system","volume":"40","author":"Lee","year":"2005","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainres.2004.05.043","article-title":"Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens","volume":"1018","author":"MacDonald","year":"2004","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J. Comp. Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2008.09.018_bib37","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/01.alc.0000183008.62955.2e","article-title":"A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration","volume":"29","author":"Marinelli","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(03)00134-0","article-title":"Understanding US addiction physicians' low rate of naltrexone prescription","volume":"71","author":"Mark","year":"2003","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.nbd.2008.09.018_bib39","first-page":"463","article-title":"CNS mechanisms of alcohol self-administration","volume":"2","author":"McBride","year":"1993","journal-title":"Alcohol Alcohol Suppl."},{"issue":"5","key":"10.1016\/j.nbd.2008.09.018_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0893-133X(99)00147-5","article-title":"Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects","volume":"22","author":"McCaul","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/JCP.0b013e31802e68b0","article-title":"The ASP-40 mu opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers","volume":"27","author":"Mitchell","year":"2007","journal-title":"J. Clin. Psychopharm."},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib42","first-page":"1634","article-title":"Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes","volume":"25","author":"Monti","year":"2001","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib43","first-page":"476","article-title":"Involvement of dopamine D2 autoreceptors in the ventral tegmental area on alcohol and saccharin intake of the alcohol-preferring P rat","volume":"24","author":"Nowak","year":"2000","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.nbd.2008.09.018_bib44","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1530-0277.1994.tb00118.x","article-title":"Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems","volume":"18","author":"Nylander","year":"1994","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.nbd.2008.09.018_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.alcalc.a008223","article-title":"Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse","volume":"1","author":"O'Malley","year":"1996","journal-title":"Alcohol Alcohol Suppl."},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib47","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence. A controlled study","volume":"49","author":"O'Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","article-title":"Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis","volume":"160","author":"O'Malley","year":"2002","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.nbd.2008.09.018_bib48","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1037\/0735-7044.111.6.1324","article-title":"The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites","volume":"111","author":"Olmstead","year":"1997","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s002130000666","article-title":"Adverse effects of oral naltrexone: analysis of data from two clinical trials","volume":"154","author":"Oncken","year":"2001","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0091-3057(92)90373-N","article-title":"Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms","volume":"41","author":"Parker","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2008.09.018_bib51","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"4","key":"10.1016\/j.nbd.2008.09.018_bib52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1521-0391.2003.tb00547.x","article-title":"Patient attitudes toward treatment predict attendance in clinical pharmacotherapy trials of alcohol and drug treatment","volume":"12","author":"Pettinati","year":"2003","journal-title":"Am. J. Addict."},{"issue":"9","key":"10.1016\/j.nbd.2008.09.018_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","article-title":"Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","volume":"64","author":"Ray","year":"2007","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.nbd.2008.09.018_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0741-8329(84)90033-8","article-title":"Morphine and naloxone modulate intake of ethanol","volume":"1","author":"Reid","year":"1984","journal-title":"Alcohol"},{"key":"10.1016\/j.nbd.2008.09.018_bib59","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT). WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.nbd.2008.09.018_bib60","first-page":"563","article-title":"Differential effects of mu and kappa opioid systems on motivational processes","volume":"75","author":"Shippenberg","year":"1986","journal-title":"NIDA Res. Monogr."},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/36.1.2","article-title":"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism","volume":"36","author":"Sinclair","year":"2001","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0741-8329(98)00064-0","article-title":"[3H]ethylketocyclazocine binding to brain opioid receptor subtypes in alcohol-preferring AA and alcohol-avoiding ANA rats","volume":"18","author":"Soini","year":"1999","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02246289","article-title":"A dose\u2013response study of the effects of alcohol on the perceptions of pain and discomfort due to electric shock in men at high familial-genetic risk for alcoholism","volume":"119","author":"Stewart","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2008.09.018_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.npp.1300487","article-title":"Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats","volume":"30","author":"Stinus","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.nbd.2008.09.018_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0741-8329(02)00280-X","article-title":"Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat","volume":"28","author":"Stromberg","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.nbd.2008.09.018_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00952999009001570","article-title":"Evaluation and treatment of adolescent substance abuse: a decision tree method","volume":"16","author":"Tarter","year":"1990","journal-title":"Am. J. Drug. Alcohol. Abuse"},{"issue":"2","key":"10.1016\/j.nbd.2008.09.018_bib67","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/jpet.103.059287","article-title":"Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat","volume":"309","author":"Terashvili","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8973","key":"10.1016\/j.nbd.2008.09.018_bib68","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(95)91316-5","article-title":"Naltrexone and alcohol dependence","volume":"346","author":"Volpicelli","year":"1995","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.nbd.2008.09.018_bib69","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","article-title":"Association of the kappa-opioid system with alcohol dependence","author":"Xuei","year":"2006","journal-title":"Mol Psychiatry"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610800226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610800226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:02:45Z","timestamp":1760850165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999610800226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S096999610800226X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.09.018","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}